219 related articles for article (PubMed ID: 29608750)
1. Impact of rapid, culture-independent diagnosis of candidaemia and invasive candidiasis in a community health system.
Patch ME; Weisz E; Cubillos A; Estrada SJ; Pfaller MA
J Antimicrob Chemother; 2018 Mar; 73(suppl_4):iv27-iv30. PubMed ID: 29608750
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.
Cornely OA; Vazquez J; De Waele J; Betts R; Rotstein C; Nucci M; Pappas PG; Ullmann AJ
Mycoses; 2014 Feb; 57(2):79-89. PubMed ID: 23786573
[TBL] [Abstract][Full Text] [Related]
3. Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics.
Aitken SL; Beyda ND; Shah DN; Palmer HR; Lasco TM; Koo H; Garey KW
Ann Pharmacother; 2014 Jun; 48(6):683-90. PubMed ID: 24687545
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of micafungin versus liposomal amphotericin B (LAmB) for treating patients with candidaemia and invasive candidiasis (IC) in Turkey.
Neoh CF; Senol E; Kara A; Dinleyici EC; Turner SJ; Kong DCM
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1777-1784. PubMed ID: 29959610
[TBL] [Abstract][Full Text] [Related]
5. Use of T2MR in invasive candidiasis with and without candidemia.
Zacharioudakis IM; Zervou FN; Mylonakis E
Future Microbiol; 2018 Aug; 13():1165-1173. PubMed ID: 29792512
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of micafungin for the treatment of invasive candidiasis and candidaemia in patients with neutropenia.
Chandrasekar P; Sirohi B; Seibel NL; Hsu JW; Azie N; Wu C; Ruhnke M
Mycoses; 2018 May; 61(5):331-336. PubMed ID: 29364548
[TBL] [Abstract][Full Text] [Related]
7. T2 magnetic resonance for the diagnosis of bloodstream infections: charting a path forward.
Clancy CJ; Nguyen MH
J Antimicrob Chemother; 2018 Mar; 73(suppl_4):iv2-iv5. PubMed ID: 29608754
[TBL] [Abstract][Full Text] [Related]
8. Utilization and impact of a rapid Candida panel on antifungal stewardship program within a large community hospital.
Steuber TD; Tucker-Heard G; Edwards J; Sawyer A; Thottacherry E; Hassoun A
Diagn Microbiol Infect Dis; 2020 Aug; 97(4):115086. PubMed ID: 32535413
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a Rapid Fungal Detection Panel for Identification of Candidemia at an Academic Medical Center.
Bomkamp JP; Sulaiman R; Hartwell JL; Desai A; Winn VC; Wrin J; Kussin ML; Hiles JJ
J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31852762
[TBL] [Abstract][Full Text] [Related]
10. Antifungal stewardship in invasive Candida infections.
Ruhnke M
Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():11-8. PubMed ID: 24661820
[TBL] [Abstract][Full Text] [Related]
11. Impact of a diagnostics-driven antifungal stewardship programme in a UK tertiary referral teaching hospital.
Rautemaa-Richardson R; Rautemaa V; Al-Wathiqi F; Moore CB; Craig L; Felton TW; Muldoon EG
J Antimicrob Chemother; 2018 Dec; 73(12):3488-3495. PubMed ID: 30252053
[TBL] [Abstract][Full Text] [Related]
12. Candidemia and Invasive Candidiasis.
McCarty TP; White CM; Pappas PG
Infect Dis Clin North Am; 2021 Jun; 35(2):389-413. PubMed ID: 34016283
[TBL] [Abstract][Full Text] [Related]
13.
Beyda ND; Amadio J; Rodriguez JR; Malinowski K; Garey KW; Wanger A; Ostrosky-Zeichner L
J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29898999
[TBL] [Abstract][Full Text] [Related]
14. Candidemia and invasive candidiasis in adults: A narrative review.
Antinori S; Milazzo L; Sollima S; Galli M; Corbellino M
Eur J Intern Med; 2016 Oct; 34():21-28. PubMed ID: 27394927
[TBL] [Abstract][Full Text] [Related]
15. T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study.
Muñoz P; Vena A; Machado M; Gioia F; Martínez-Jiménez MC; Gómez E; Origüen J; Orellana MÁ; López-Medrano F; Fernández-Ruiz M; Merino P; González-Romo F; Frías I; Pérez-Granda MJ; Aguado JM; Fortún J; Bouza E;
J Antimicrob Chemother; 2018 Mar; 73(suppl_4):iv6-iv12. PubMed ID: 29608751
[TBL] [Abstract][Full Text] [Related]
16. Economic evaluation of micafungin vs. liposomal amphotericin B (LAmB) for the treatment of candidaemia and invasive candidiasis (IC).
Neoh CF; Liew D; Slavin MA; Marriott D; Chen SC; Morrissey O; Stewart K; Kong DC
Mycoses; 2013 Sep; 56(5):532-42. PubMed ID: 23496163
[TBL] [Abstract][Full Text] [Related]
17. Diagnosing candidemia with the T2Candida panel: an instructive case of septic shock in which blood cultures were negative.
Clancy CJ; Nguyen MH
Diagn Microbiol Infect Dis; 2019 Jan; 93(1):54-57. PubMed ID: 30316561
[TBL] [Abstract][Full Text] [Related]
18. Pharmacoeconomic evaluation of micafungin versus caspofungin as definitive therapy for candidaemia and invasive candidiasis (IC) in Turkey.
Neoh CF; Senol E; Kara A; Dinleyici EC; Turner SJ; Kong DCM
Eur J Clin Microbiol Infect Dis; 2018 Mar; 37(3):537-544. PubMed ID: 29185089
[TBL] [Abstract][Full Text] [Related]
19. Rapid diagnosis of invasive candidiasis: ready for prime-time?
Clancy CJ; Nguyen MH
Curr Opin Infect Dis; 2019 Dec; 32(6):546-552. PubMed ID: 31567567
[TBL] [Abstract][Full Text] [Related]
20. Candidemic complications in patients with intravascular catheters colonized with Candida species: an indication for preemptive antifungal therapy?
Leenders NH; Oosterheert JJ; Ekkelenkamp MB; De Lange DW; Hoepelman AI; Peters EJ
Int J Infect Dis; 2011 Jul; 15(7):e453-8. PubMed ID: 21530350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
